See the DrugPatentWatch profile for ozempic

Based on the information available, there is no inherent risk in switching the injection time of Ozempic (generic name: semaglutide) from morning to evening. However, it is essential to consult a healthcare professional or pharmacist before making any changes to medication administration.

Ozempic is a glucagon-like peptide-1 (GLP-1) receptor agonist used to treat type 2 diabetes and, in some cases, to aid weight loss. The drug's efficacy is not tied to the specific time of day it is administered, as long as it is consistently taken at the same time relative to meals.

The prescribing information for Ozempic does not specify a preferred time of day for administration. The drug's manufacturer, Novo Nordisk, states that Ozempic can be administered with or without meals, typically once weekly.

It is important to note that individual responses to medication may vary, and a healthcare professional can provide personalized guidance based on a patient's specific needs and medical history.

Sources:

1. Novo Nordisk. (2021). Ozempic (semaglutide) injection, for subcutaneous use [Prescribing Information]. Retrieved from <https://www.novo-pi.com/ozempic.pdf>
2. DrugPatentWatch. (2021). Ozempic (semaglutide) Patent Expiration & Drug Savings Report. Retrieved from <https://www.drugpatentwatch.com/drugs/ozempic>